Dr. Georges Sayed Damaa, MD

Dr. Damaa practices at Arh Daniel Boone Clinic Harlan - Primary Care - HOPD in Harlan, Kentucky.

Dr. Damaa's NPI, 1285839910, was assigned on June 21, 2007. Dr. Damaa holds Kentucky license 44402.

Dr. Damaa's primary practice is Arh Daniel Boone Clinic Harlan - Primary Care - HOPD, at 37 Ball Park Rd, Harlan, KY 40831.

Dr. Damaa's primary practice is Arh Daniel Boone Clinic Harlan - Primary Care - HOPD in Harlan, Kentucky. Dr. Damaa is also affiliated with Harlan ARH Hospital. The medical group on file is ARH Pennington Gap Clinic. Dmand AI also links Dr. Damaa to 3 more hospitals and 1 rural health clinic, each named with a free account. Dr. Damaa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Damaa practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Damaa's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Damaa is licensed in Kentucky.

CMS data shows 865 Medicare services from Dr. Damaa across 12 procedure codes in 2024, for 237 Medicare patients. Medicare paid $57,926 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Damaa in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Damaa's median patient age at 63, with 56% women.

In 2024, Dr. Damaa wrote 3,268 Medicare Part D claims for 491 patients. 89% of them were for generic drugs. CMS names the drug for 3,122 of them, across 37 drugs with 11 or more claims each, at $243,536 in total drug cost. In 2023, CMS named 2,853 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Damaa for performance year 2024, reported through an alternative payment model (APM). Dr. Damaa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Damaa, published from 2012 to 2023. Dr. Damaa's most frequent co-authors are Nazneen Ahmed, MD, Mayur Jivrajbhai Lakhani, MD and Tarun R. Nagrani, MD.

CMS Open Payments shows 33 general payments to Dr. Damaa from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Medtronic, Inc. paid the most, $440.